Tian‐Ying Xu
- Molecular Biology top 10%
- Epidemiology top 5%
- Physiology top 5%
- Geriatrics and Gerontology top 0.5%
- Oncology top 10%
- Co-authors
- Chao‐Yu MiaoPei WangYun‐Feng GuanDing‐Feng SuShu‐Na WangBenoı̂t ViolletZhiyong LiGuorong Fan
- Topics
- Sirtuins and Resveratrol in Medicine (11 papers)PARP inhibition in cancer therapy (7 papers)Adipose Tissue and Metabolism (7 papers)
In The Last Decade
Tian‐Ying Xu
34 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 112
- Molecular Biology 806
- Epidemiology 571
- Physiology 435
- Geriatrics and Gerontology 425
- Oncology 278
Countries citing papers authored by Tian‐Ying Xu
This map shows the geographic impact of Tian‐Ying Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tian‐Ying Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tian‐Ying Xu more than expected).
Fields of papers citing papers by Tian‐Ying Xu
This network shows the impact of papers produced by Tian‐Ying Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tian‐Ying Xu. The network helps show where Tian‐Ying Xu may publish in the future.
Co-authorship network of co-authors of Tian‐Ying Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Tian‐Ying Xu. A scholar is included among the top collaborators of Tian‐Ying Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tian‐Ying Xu. Tian‐Ying Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 22 | |
| 3 | 25 | |
| 4 | 7 | |
| 5 | 43 | |
| 6 | 86 | |
| 7 | 89 | |
| 8 | 56 | |
| 9 | 17 | |
| 10 | 51 | |
| 11 | 96 | |
| 12 | 60 | |
| 13 | 120 | |
| 14 | 5 | |
| 15 | 45 | |
| 16 | 84 | |
| 17 | 53 | |
| 18 | 258 | |
| 19 | Expressions of CD133 in hepatocellular carcinoma and its clinical significance. | 1 |
| 20 | 17 |
About Tian‐Ying Xu
Tian‐Ying Xu is a scholar working on Geriatrics and Gerontology, Developmental Neuroscience and Physiology, having authored 35 papers that have together received 1.9k indexed citations. Recurring topics across this work include Sirtuins and Resveratrol in Medicine (11 papers), PARP inhibition in cancer therapy (7 papers) and Adipose Tissue and Metabolism (7 papers). The work is most often cited by research in Geriatrics and Gerontology (425 citations), Physiology (174 citations) and Developmental Neuroscience (91 citations). Tian‐Ying Xu has collaborated with scholars based in China, France and Hong Kong. Frequent co-authors include Chao‐Yu Miao, Pei Wang, Yun‐Feng Guan, Ding‐Feng Su, Ding‐Feng Su, Shu‐Na Wang, Benoı̂t Viollet, Zhiyong Li, Guorong Fan and Jie Song. Their work appears in journals such as PLoS ONE, Diabetes and Analytical Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.